Supplemental Materials for JAAD Publication JAAD-D-21-01712R3, Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia Areata
Published: 23 March 2022| Version 1 | DOI: 10.17632/jgpsf32f86.1
Contributors:
, Natasha Atanaskova Mesinkovska, Paradi Mirmirani, Suzanne Bruce, Steve Kempers, Emma Guttman-Yassky, Janet Roberts, Amy McMichael, Maria Colavincenzo, Colleen Hamilton, Ginny Braman, Jim CassellaDescription
These are supplemental data sets to the JAAD publication entitled "Phase 2 Randomized, Dose-Ranging Trial of CTP-543, a Selective Janus Kinase Inhibitor, in Moderate to Severe Alopecia Areata". Supplemental figures include: Figure S1: Enrollment and Patient Disposition; Figure S2: Patient SALT Improvement Thresholds; Figure S3: Percentage of Patients Achieving SALT score ≤20 Over Treatment Period; Figure S4. Patient-Reported Outcomes.
Files
Categories
Hair Disorder, Management of Hair Loss Symptom, Alopecia Areata, Janus Kinase